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Abstract
chronic pancreatitis (cP) is a destructive inflammatory condition that leads to progressive morphological and functional changes and is
characterised by significant abdominal pain. When formally assessed, pain has been demonstrated to affect all aspects of patients’
health-related quality of life (hrQL). it is widely acknowledged that, in a patient-centred healthcare system, treatment should not just
measure the success of controlling symptoms, but also the effect on the patients’ perceived wellbeing and hrQL. We review various
hrQL assessment questionnaires used to assess patients with cP, how they have been used to assess the success of various treatment
methods for cP, and the challenges in interpreting the information.
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chronic  pancreatitis  (cP)  is  a  destructive  inflammatory  condition  that
leads to progressive morphological and functional changes at each stage
of  the  disease.  This  is  manifest  by  recurrent  episodes  of  mild  acute
pancreatitis that result pathologically in fibrosis, with associated loss of
exocrine  and  endocrine  function,  causing  malnutrition,  diabetes  and
significant pain. in a half to two-thirds of cases, it is caused by persistent
excessive alcohol consumption, however, in approximately one-third of
cases,  the  aetiology  is  idiopathic,  and  caused  by  rarer  entities  in  the
remainder.
1 Treatment  is  based  around  three  principles:  optimising
nutrition  by  pancreatic  enzyme  supplementation  and  regular  dietetic
review;  alleviating  pain  using  medical  and  surgical  intervention;  and
controlling  diabetes.  each  may  result  in  significant  improvement  in
symptoms, however controlling pain still remains the most challenging
aspect of care. recent advances in non-surgical therapeutic modalities, 
in  particular  interventional  endoscopy  and  radiology,  have  created
intermediate  options  between  medical  treatment  and  surgery.  When
reviewing therapeutic options, it is imperative to ascertain the efficacy and
impact of disease and treatment on patients’ health-related quality of life
(hrQL). Patients’ hrQL is becoming increasingly important, as we seek to
develop  patient-centred  healthcare  systems,  as  the  demand  for
healthcare is rising and the pressures to control spending are intensifying.
There is therefore a need to quantify the impact of these therapies, which
has required the development of formal tools to allow measurement of
hrQL. This is particularly true for chronic diseases, for which treatments
often aim to improve symptoms rather than achieve a cure or prevent
death. This article will review tools used to measure hrQL and the effect
of therapeutic interventions on hrQL in patients with cP.
Measuring Health-related Quality of Life
While there have been no hrQL questionnaires specifically designed
for  assessing  patients  with  cP,  there  has  been  much  interest  in
validating pre-existing questionnaires such as the Medical outcome
study  36-item  short-form  health  survey  (sf-36)
2 and  the  european
organisation  for  research  and  Treatment  of  cancer  Quality  of  Life
Questionnaire c-30 (eorTc QLQ-c30).
3
The sf-36 is a generic hrQL tool that assesses eight domains of health.
Two summary measurements can then be calculated for physical and
mental  health.  Although  the  sf-36  was  designed  for  population
screening, and lacks the ability to document detailed, disease-specific
aspects of hrQL, it is known to demonstrate reliability and validity across
a diverse range of populations and diseases and is a feasible, reliable and
valid measure for descriptive studies of populations of patients with cP.
2,4
The sf-36 takes on average 12 minutes to complete, limiting its use in
outpatient  clinic  settings.
5 The  sf-12  questionnaire  was  therefore
developed, incorporating 12 questions from the sf-36.
6 comparison of
the two questionnaires, whereby the sf-12 answers were taken from
answers  given  in  the  sf-36,  rather  than  being  given  separately,
demonstrated that there was a good correlation between the physical
component summary and the mental component of these two versions
of the questionnaire (r=0.960, p<0.001).
5 The minimal time required to
complete the sf-12 consequently provides potential for its use as an
outpatient  screening  tool  of  patients  with  cP.  furthermore  its  use  in
clinical research studies may lead to an improvement in prospective data
collection  as  a  less  time-consuming  questionnaire  may  encourage
ongoing patient participation and thus reduce the ‘dropout’ rate.
The eorTc core cancer module, QLQ-c30, was initially designed to
assess hrQL of patients with all types of cancer. The PAn-26 was then
developed to supplement the eorTc QLQ-c30 to specifically assess
patients with pancreatic cancer.
7 Both questionnaires have since been
validated for use in cP.
8 Although the eorTc QLQ-c30 and QLQ-PAn26
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disease, structured interviews of patients with cP who completed the
questionnaires demonstrated important areas specific to the disease
that were not covered, including guilt about alcohol consumption and
the burden of abstinence.
8 We have added questions relating to these
areas  to  create  a  questionnaire  (QLQ-PAn28  [cP])  that  can  provide
detailed assessment of the issues affecting patients with cP, as well as
an overall estimate of quality of life.
8
Treatment Modalities and their Effect on
Health-related Quality of Life
There are inherent difficulties in comparing different studies that have
used  the  same  questionnaire  because  it  is  widely  accepted  that
cultural and environmental differences lead to a variation in approach
to  disease  and  its  impact.
8 furthermore,  assessing  the  relationship 
of pain to hrQL is problematic as pain presentation is so variable and
the  pain  scales  used  in  the  literature  are  heterogeneous.  Pain  and 
a  patient’s  perception  of  pain  are  therefore  complex.  however,
ineffective relief of chronic pain can result in patients experiencing
feelings of hopelessness and isolation.
9 The three hrQL questionnaires
that  have  been  validated  in  cP  (sf-36,  sf-12,  eorTc  QLQ-c30  and
QLQ-PAn28 [cP]) have demonstrated that pain influences all areas of
hrQL assessed.
8,10–12 A Polish study by Mokrowiecka et al. showed that
pain intensity rather than frequency had the greatest effect on hrQL.
12
in contrast, Mullady et al. concluded from data derived from the ‘north
American Pancreatitis study 02’, that patients with cP with constant
pain,  regardless  of  severity,  had  higher  rates  of  disability,
hospitalisation  and  pain  medication  consumption,  as  well  as  lower
hrQL  scores,  in  comparison  to  patients  with  cP  with  intermittent
pain.
13 however, while pain is the dominant symptom demonstrated to
effect hrQL, a number of additional themes have been generated from
standardised interviews with patients with cP: anxiety and depression
are common, along with social isolation and concern over body image.
Patients’ coping strategies are influenced by the severity of physical
and emotional symptoms as well as external factors such as financial
problems  and  employment  status.  in  addition,  fatigue,  fear  of  the
future and difficulty sleeping are all significant issues affecting hrQL in
cP.
8 This review now addresses how different treatment methods for cP
affect hrQL, and in particular, it will focus on the treatment of pain. 
Medical Management of Pain
The use of analgesic drugs to alleviate pain in cP is well described and
involves a stepwise progression from simple analgesia through to the use
of opiates. narcotic addiction is a concern for clinicians managing patients
with any chronic pain condition. Patients receiving opiate analgesia report
worse hrQL in all function scales, as well as pain and nausea symptom
scales.
8 This may be explained by greater disease activity in the patients
requiring opiates. early referral for surgery of patients with cP, whose
condition has failed to respond to conservative medical treatment, may
enable definitive treatment before there is a reliance on opiates.
interest has increased in the use of antioxidants as a medical therapy for
cP and the eorTc QLQ-c30 and QLQ-PAn28 (cP) have recently been
used to assess response.
14–16 After correction for disease duration and
cigarette smoking, it was found that patients taking antioxidant therapy
had better pain scores and required less analgesia. furthermore, global
hrQL  scores  were  significantly  better  than  for  those  not  taking
antioxidants. The efficacy and benefits of antioxidants on hrQL in cP are
being investigated in the euroPAc2 trial: a randomised double-blind
trial of antioxidants for pain relief in hereditary and idiopathic cP. 
Endoscopy and Extracorporeal 
Shockwave Lithotripsy
obstruction of the main pancreatic duct resulting in upstream dilatation
may  be  managed  endoscopically  by  ductal  decompression  with
extracorporeal lithotripsy and/or endoscopically placed pancreatic duct
stents.
17 Brand  et  al.  assessed  the  effect  on  hrQL  of  extracorporeal
shockwave  lithotripsy  (esWL)  in  combination  with  interventional
endoscopy (sphincterotomy) in 48 prospectively enrolled patients with
chronic calcified pancreatitis. forty-five per cent of patients experienced
complete pain relief, 37ﾠ% partial pain relief and a significantly improved
global health score was demonstrated following the procedure. Aspects
of the symptom scales of the eorTc QLQ-c30 that improved the most
were pain, jaundice, weight loss and fever.
18 in contrast, a number of
papers  have  identified  no  difference  in  hrQL  when  assessed  after
previous endoscopic management.
8,10–12 one potential explanation for this
is that the median duration of symptomatic disease in the Brand study
was shorter (69 months; range 1–300 months) with a short length of
follow up (median seven months),
18 whereas the patients in the other
studies  who  did  not  demonstrate  an  improvement  in  hrQL  following
previous  endoscopic  management  had  a  longer  duration  of  disease.
Dumonceau et al. suggested that, when endoscopy is added to esWL, the
total  healthcare  cost  may  increase  without  additional  clinical  benefit
compared with esWL alone.
19 in this randomised trial, 38ﾠ% of patients
who received esWL alone had pain relapse after two years compared
with 45ﾠ% of patients who received esWL with endoscopic drainage of 
the main pancreatic duct. The mean duration of hospital stay and the
frequency of subsequent procedures were also lower in the esWL group. 
There is continued scepticism about the benefit of esWL because there
is evidence that surgical management and drainage may be superior 
to  endoscopic  drainage.  cahen  et  al.  randomised  39  patients  to
endoscopic  treatment,  including  lithotripsy,  or  to  surgical
pancreaticojejunostomy.
20 After  24  months,  there  was  a  significant
reduction in izbicki pain scores in the surgical group compared with the
endoscopic group. Patients in the endoscopic group also required more
subsequent  procedures  than  those  who  underwent  surgical
management. We may conclude from this that esWL and endoscopic
therapy,  while  achieving  short-term  benefit,  may  simply  delay  the
inevitable surgery that is required for a longer-lasting clinical benefit. 
in support of this theory, nealon et al. reported on a prospective study
of 143 patients with cP.
21 They demonstrated that in patients with mild
to  moderate  cP  (disease  severity  graded  on  a  five-point  system
designed by the author), surgical pancreatic decompression stopped the
progression of pancreatic functional deterioration in a high proportion of
patients.  They  therefore  concluded  that  early  surgical  intervention
should  be  considered  in  selected  patients.  A  small  randomised  trial
within that larger series confirmed the benefit of early surgery.
Coeliac Block and Thoracoscopic
Splanchnicectomy
A  systematic  review  reported  that  the  overall  success  rate  in  terms 
of  pain  reduction  following  thoracoscopic  splanchnicectomy  in 
16 published series was 90ﾠ% for the first six months, but diminished
with the length of follow-up.
22 The high success rates reported were
either from a short follow-up or from application of stringent criteria for
patient  selection.  howard  et  al.  analysed  patients  from  two  subsets
following thoracoscopic splanchnicectomy – those who had had prior
surgery or endoscopic management and those who had not.
23 The group
with no prior surgical or endoscopic intervention did significantly better
initially following thoracoscopic splanchnicectomy (p<0.007); however,
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Table 1: A Summary of Published Articles Assessing Health-related Quality of Life with Less Than Three Years 
of Follow-up After Various Surgical Procedures Used to Treat Chronic Pancreatitis 
Author and            Patient             Surgical Procedure     Follow-Up          HRQL                         Administration of                Outcome and
Reference              Number           (Patient Number         in Months          Questionnaire            HRQL Questionnaire           Comments
                                                      in Group)                    (Median)
Bloechle
33                 25                      Beger (25)                     18                        eorTc QLQ-c30,         •  Twice before surgery       •  significant improvement in hrQL
                                                                                                                           spitzer’s hrQL index    •   At discharge                     •  The pain score decreased by
                                                                                                                                                               •  6 and 18 months                  95 % (p<0.001)
                                                                                                                                                                    after surgery                     
varghese
34               21                      Beger (21)                     24                        eorTc-QLQ-c30          •  one after surgery             •  global hrQL score for patients 
                                                                                                                                                                                                                  with cP less than the 
                                                                                                                                                                                                                  general population
                                                                                                                                                                                                              •  retrospective
Witzigmann
35            70                      Beger (38) versus         34                        eorTc QLQ-c30          •  Week before surgery        •  Better hrQL functional score
                                                          PD (32)                                                                                         •  2–12 and 18–24 months       and symptom scores in all
                                                                                                                                                                    after surgery                         parameters except cognitive
                                                                                                                                                                                                                  function in the Beger group
                                                                                                                                                                                                              •  PD performed if suspected 
                                                                                                                                                                                                                  cancer thus different 
                                                                                                                                                                                                                  pre-operative patient 
                                                                                                                                                                                                                  expectation
izbicki
36                    42                      Beger (20) versus         18                        visual analogue          •  one before surgery          •  global hrQL and working ability
                                                          frey (22),                                                 pain scale,                   •  one after surgery                 improved by 67 % and 50 % in 
                                                          randomised                                             eorTc QLQ-c30                                                            the Beger and frey groups
                                                                                                                                                                                                              •  fatigue improved significantly
                                                                                                                                                                                                                  more in the Beger group 
                                                                                                                                                                                                                  compared with the frey group
izbicki
37                    61                      frey (31) versus           24                        eorTc QLQ-c30          •  one before surgery          •  Median global hrQL improved 
                                                          PPPD (30),                                                                                    •  one after surgery                 by 200 % in the frey group and 
                                                          randomised                                                                                                                                    100 % in the PPPD group
                                                                                                                                                                                                              •  Physical status and working
                                                                                                                                                                                                                  ability scores improved by 67 %
                                                                                                                                                                                                                  and 50 % in both groups
Koninger
38                65                      Beger (32) versus          24                        eorTc QLQ-c30          •  one before surgery          •  no significant difference in hrQL 
                                                          Berne (33), randomised                                                                •  one after surgery                 between the two groups
Keleman
39                66                      Beger (32), frey (13),    20.6 (frey)          giQLi                            •  one after surgery             •  giQLi score better following
                                                          PPPD (21)                     41.5 (Beger)                                                                                               Beger compared with PPPD
                                                                                                                                                                                                              •  retrospective
sohn
40                      255*                  PD (96), DP (67),           32.5                     visual analogue          •  one time point                 •  improved perception of hrQL, 
                                                          Puestow (52),                                           quality of life                    after surgery                         ability to care for themselves 
                                                          sphincteroplasty (37),                               questionnaire                                                                and perception of health status
                                                          Duval (5),                                                                                                                                    •  significantly reduced pain at
                                                          miscellaneous (6)                                                                                                                           follow up
                                                                                                                                                                                                              •  Decline in employment
                                                                                                                                                                                                                  following surgery
                                                                                                                                                                                                              •  retrospective
                                                                                                                                                                                                              •  Poor hrQL response rate (47 %)
                                                                                                                                                                                                              •  Bias in age of patients responding
                                                                                                                                                                                                                              to hrQL questionnaire (may
                                                                                                                                                                                                                              under-represent the number of
                                                                                                                                                                                                                  patients returning to employment
rodriguez
41              22                      Total pancreatectomy  19                        sf-36, Mcgill Pain       •  one before surgery          •  significant reduction in 
                                                          with islet cell                                           Questionnaire             •  19 months after surgery      frequency, duration and 
                                                          transplant                                                                                                                                       intensity of pain
                                                                                                                                                                                                              •  significant increase in hrQL
                                                                                                                                                                                                                  following procedure
                                                                                                                                                                                                              •  only 11 out of 22 responded to
                                                                                                                                                                                                                  hrQL questionnaire
sutton
42                    118                    Total pancreatectomy   22**                    sf-36, Mcgill Pain       •  one before surgery          •  All patients, including those still
                                                              with islet cell transplant                          Questionnaire             •  one after surgery                 on narcotics, reported 
                                                                                                                                                                                                                  improvement in physical, 
                                                                                                                                                                                                                  emotional and overall hrQL
                                                                                                                                                                                                              •  Population assessed presumed
                                                                                                                                                                                                                  genetically linked cP, but not all
                                                                                                                                                                                                                  patients underwent formal 
                                                                                                                                                                                                                  genetic testing
* 255 patients had 263 operations in total; ** mean; CP = chronic pancreatitis; DP = distal pancreatectomy; EORTC QLQ-C30 = European Organisation for Research and Treatment of Cancer
Quality of Life Questionnaire C-30; GILQI = Gastrointestinal Quality of Life Index; HRQL = health-related quality of life; PD = pancreaticoduodenectomy; PPPD = pylorus preserving
pancreaticoduodenectomy; SF-36 = Medical Outcome Study 36-item Short-form Health Survey.Quality of Life in Chronic Pancreatitis
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after a median follow-up of 32 months, 38 of 55 patients (69ﾠ%) reported
a return of abdominal pain. Despite discouraging results in the literature,
it should be noted that, in one study, two-thirds of patients replied that
they would have a splanchnicectomy again and thought that the pain
relief  they  experienced,  albeit  short-term,  was  worthwhile.
24 Perhaps
one could conclude that this procedure, which is not without its risks,
may  be  delaying  the  inevitable  step  to  requiring  pancreatic  surgery,
although it may still be suitable for some selected patients, in particular
those who are unsuitable for major abdominal surgery. 
Less well reported in the literature are results from coeliac plexus block.
one study compared neurolytic coeliac plexus block with thoracoscopic
splanchnicectomy.
25 Two  different  hrQL  assessments  were  used  to
measure  outcomes  between  the  two  groups  so  a  meta-analytical
approach  was  taken.  The  effect  on  social  wellbeing  and  emotional
support  was  significantly  higher  in  the  coeliac  plexus  block  group
compared with the thoracoscopic splanchnicectomy group. The authors
hypothesise that this may be because the coeliac plexus block was the
first intervention available, whereas the patients in the thoracoscopic
Table 2: A Summary of Published Articles Assessing Health-related Quality of Life with More Than Three Years 
of Follow-up After Various Surgical Procedures to Treat Chronic Pancreatitis 
Author and             Patient             Surgical                      Follow-Up          HRQL                         Administration of               Outcome and
Reference              Number           Procedure                  in Months          Questionnaire           HRQL Questionnaire           Comments
                                                      (Patient Number)       (Median)
Mobius
43                   51                      PD (24) versus              63.5                     eorTc QLQ-c30          •   Before surgery                 •   significantly improved hrQL in 
                                                          Beger (27)                                                                                     •   shortly after surgery            Beger group
                                                                                                                                                               •   five years after surgery  
King
44                        72*                    PPPD (40), frey (16),    72**                    sf-36,                          •   one after surgery            •   significantly improved hrQL
                                                          DP (1), other (18)                                      eorTc QLQ-c30                                                            scores compared with
                                                                                                                           and PAn-26                                                                 ‘historical controls’ in
                                                                                                                                                                                                                  the eorTc QLQ-c30 
                                                                                                                                                                                                              •   only 45 % of patients completed
                                                                                                                                                                                                                  hrQL questionnaires
                                                                                                                                                                                                              •   retrospective
strate
45                     61                      PPPD (30) versus         84                        eorTc QLQ-c30          •   After surgery                    •   There were no differences
                                                          frey (31)                                                                                                                                          in hrQL between both groups 
                                                                                                                                                                                                              •   47 patients followed up for
                                                                                                                                                                                                                  seven years
strate
46                     74                      Beger (38) versus         104                      eorTc QLQ-c30          •   one early and late           •   no significant difference in 
                                                          frey (36),                                                                                           follow up after surgery         hrQL between procedures
                                                          randomised                                                                                                                                •   26 patients professionally
                                                                                                                                                                                                                  rehabilitated
                                                                                                                                                                                                              •   51 patients completed 
                                                                                                                                                                                                                  hrQL questionnaire
M￼ller
47                     40                      Beger (20) versus         84 and 168          eorTc QLQ-c30          •   one before surgery         •   no difference in global health 
                                                          PPPD (20)                                                                                     •   one at seven years              status or score on any of the 
                                                                                                                                                                    after surgery                         functional scales of the eorTc 
                                                                                                                                                               •   one at 14 years after           QLQ-c30 at 7- and 14-year 
                                                                                                                                                                    surgery                                 follow up, and results similar to 
                                                                                                                                                                                                                  those of a normal german adult 
                                                                                                                                                                                                                  population (see Table 2)
Behrman
48                35                      Total                             46**                    sf-36                           •   one after surgery            •   hrQL diminished in patients  
                                                          pancreatectomy (7),                                                                                                                        with cP despite surgery
                                                          other (28)                                                                                                                                        compared with normal 
                                                                                                                                                                                                                  gender-matched controls
                                                                                                                                                                                                              •   very heterogeneous population
                                                                                                                                                                                                                  having a number of different
                                                                                                                                                                                                                  surgeries
                                                                                                                                                                                                              •   retrospective
schnelldorfer
49         372                    Lateral PJ (184),            66                        sf-36                           •   one after surgery            •   half the patients continued to
                                                          PD (97), DP (91)                                                                                                                              experience persistent pain
                                                                                                                                                                                                              •   hrQL scores indicated that
                                                                                                                                                                                                                  some benefit was obtained 
                                                                                                                                                                                                                  from surgery
                                                                                                                                                                                                              •   retrospective
Kalady
50                    60                      Lateral PJ (60) versus   38                        sf-36                           •   one after surgery            •   overall physical and mental 
                                                          controls (debridement                                                                                                                     hrQL scores were diminished 
                                                          and laparoscopic                                                                                                                            in patients with cP compared 
                                                          cholecystectomy)                                                                                                                         with controls
                                                                                                                                                                                                              •   Appropriateness of control
                                                                                                                                                                                                                 population?
                                                                                                                                                                                                              •   retrospective
* 72 patients had 75 operations in total; ** mean; CP = chronic pancreatitis; DP = distal pancreatectomy; EORTC QLQ-C30 = European Organisation for Research and Treatment of Cancer
Quality of Life Questionnaire C-30; HRQL = health-related quality of life; PD = pancreaticoduodenectomy; PPPD = pylorus preserving pancreaticoduodenectomy; SF-36 = Medical Outcome
Study 36-item Short-form Health Survey.splanchnicectomy group had a longer duration of chronic pain and had
had  previous  intervention.  Both  interventions  resulted  in  significantly
reduced pain and opiate requirements; however, it is difficult to draw
conclusions from this study about the long-term effect of coeliac plexus
block as patients were only followed up for eight weeks after treatment.
Exocrine and Endocrine Insufficiency 
The destruction of exocrine tissue along with secondary inactivation
of enzymes and bile acid, with reduced delivery of bicarbonate to the
duodenum, results in maldigestion. other factors including poor oral
intake due to pain or excessive alcohol consumption compound the
situation  further,  culminating  in  malnutrition.
26 Pancreatic  enzyme
replacement  therapy  (PerT)  improves  digestion  and  therefore
reduces steatorrhoea and the loss of fat-soluble vitamins. it has been
proposed  that  PerT  may  also  reduce  pain  associated  with  cP,
potentially through suppression of cholecystokinin-releasing peptide.
Another  possible  mechanism  for  pain  (or  abdominal  discomfort)  in
malabsorption is colonic distension due to the accumulation of bulky
stools.  Ten  randomised  controlled  trials  from  1965  to  2009  were
included in a recent cochrane review to evaluate the effect of PerT.
Although some of the individual studies reported improved abdominal
pain  and  reduced  steatorrhoea,  the  heterogeneity  of  the  studies
prevented the pooling of results.
26 The majority of the trials had small
numbers of patients and only short-term follow-up data, and only one
trial measured hrQL as an outcome.
27 however, this trial did not meet
the  inclusion  criteria  of  the  cochrane  review  but  concluded  that
hrQL,  pain  and  steatorrhoea  were  improved  following  PerT  and 
that working ability and financial strain were significantly improved. 
numerous studies have demonstrated a correlation between low body
mass  index  and  reduced  hrQL,  including  both  physical  and  mental
domains.
10–12 This  highlights  the  importance  of  treating  maldigestion
adequately. even when PerT has been prescribed, it has to be considered
that adherence to treatment and appropriate usage may be an issue in 
a significant number of patients. Dom￭nguez-Mu￱oz and iglesias-garc￭a
identified  that  a  clinical  response  to  PerT,  including  a  reduction  in
steatorrhoea,  does  not  necessarily  imply  adequate  nutrition.
28 Trials
addressing long-term outcome and hrQL are required to draw definitive
conclusions. Malnutrition may therefore be a significant issue requiring
ongoing dietetic review and education even if symptoms have improved.
Diabetes mellitus (DM) complicates cP in approximately one-third of cases
and  is  an  independent  risk  factor  for  mortality.
29,30 DM  in  association 
with cP is particularly unpredictable and is frequently associated with
hypoglycaemic episodes.
31 This is largely attributable to unopposed insulin
action  with  a  reduced  basal  level  of  glucagon,  although  increased
intestinal transit with associated carbohydrate malabsorption, potential
concomitant  hepatic  impairment  and  poor  compliance  with  lifestyle
changes and medication may also contribute.
32 studies have reported that
DM significantly impairs hrQL in the physical and/or mental domains of
the sf-36 and eorTc QL Q-c30 assessments.
10,11 it is clear that attention
to  exocrine  function  and  nutrition,  and  the  involvement  of  dieticians,
diabetologists and specialist nurses, is important in improving long-term
outcomes and a patient’s hrQL.
The Role of Surgery
surgery for cP has progressed from radical to duodenum-preserving
surgery,  which  is  beneficial  for  digestion,  nutrition  and  glucose
metabolism. The Whipple procedure (pancreaticoduodenectomy)
51 was
long  established  as  being  effective  for  the  management  of  the
complications  of  cP;  however,  the  duodenum-preserving  pancreatic
head  resection  (Beger  procedure)  was  subsequently  introduced  as
subtotal  resection  of  the  pancreatic  head  and  preservation  of  the
duodenum allows normal food passage and insulin secretion. A number
of studies have used hrQL questionnaires to measure outcome (see
Tables  1  and  2),  with  the  eorTc  QLQ-c30  questionnaire  being  used
more frequently than the sf-36. The Beger procedure has been shown
to be superior to pancreaticoduodenectomy (PD) and pylorus preserving
pancreaticoduodenectomy  (PPPD)  in  improving  hrQL,  although  the
follow-up period has often been short.
35,39 interestingly, in a study with
longer follow-up (7 and 14 years), the superiority of the Beger procedure
over PD and PPPD in terms of hrQL diminished over time.
47
The  frey  procedure  involves  local  pancreatic  head  resection  with
longitudinal pancreaticojejunostomy. This procedure was found to be
superior  to  PPPD  in  terms  of  hrQL  outcome  in  the  short  term  in 
a study by izbicki et al.
36; however the Beger procedure was shown to
demonstrate superiority over the frey procedure in relieving patient
fatigue.
37 Again, the benefit of the frey procedure over PPPD, and the
Beger procedure over the frey procedure was not demonstrated in
the long term after 84 and 104 months of follow-up, respectively.
45,46,48
Although there are a lot of hrQL data comparing two procedures, there
is limited evidence of surgical procedures compared with controls in
patients with cP who have not had surgery. A number of studies have
been  retrospective,  with  associated  bias,  or  have  only  administered
questionnaires  postoperatively,  making  it  difficult  to  determine  any
improvement  in  hrQL  after  surgery.
34,39,40,44,49,50 however,  it  should  be
considered that it would be difficult to prospectively collect data for 
a population of patients with cP over a long period of time. Also of note
is that some patients in the above studies had a PD due to suspected
malignancy, and were then later found to have cP following histological
examination of the resection specimen.
35 The relief of the patients and
their expectations after receiving a benign diagnosis are likely to have
affected their perception of hrQL, and should be acknowledged when
interpreting  the  results.  To  further  complicate  matters,  a  significant
hindrance to comparing studies is the relatively large number of patients
who did not complete the hrQL questionnaires, with several studies
reporting a lack of response of more than 50ﾠ%.
40,41 Perhaps a shorter
questionnaire such as the sf-12 could increase response rate and lead
to improved prospective data collection. A number of studies assessing
factors  associated  with  hrQL  in  patients  with  chronic  pancreatitis
concluded  that  surgery  and  previous  endoscopic  treatment  had  no
benefit on hrQL.
8,10,11 The likely explanation for this finding may be the
difference in duration of follow-up among studies and the selection of
patients. for conclusions to be made, more randomised controlled trials
are required with larger populations and long-term follow up. 
Alternative Therapies
stress reduction and anxiety management programmes can be useful
for patients with chronic disease.
52. There has been one controlled trial
exploring the use of yoga as an intervention for the management of
cP.
53 The  results  implied  that  mindfulness  and  meditation-based
exercises significantly improved overall hrQL, stress symptoms, mood
changes, appetite and alcohol dependency. While acknowledging that
with only a 12-week follow up there are limitations to this study, it does
suggest that clinicians should remain open to complementary therapies
that may improve a patient’s hrQL.
Psychology and Health-related Quality of Life
each patient’s psychological approach to chronic disease may explain
the variability of perceived hrQL among patients with similar symptoms
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conceptualises factors influencing patients’ behaviours and judgement,
including  cognitive  representation  of  the  threat  of  the  disease,  the
emotional reaction to the disease, the coping mechanisms the patient
uses to deal with the emotions created from the disease threat, and
finally, the patient’s contextual factors, e.g., social roles.
54
Psychologists have been employed in varying multidisciplinary teams
managing patients with chronic disease, and may help patients to cope
with  disease  burden.  furthermore,  a  better  understanding  of
psychological factors affecting a patient may reveal why certain patients
will  not  complete  hrQL  questionnaires.  Pezzilli  et  al.  have  best
characterised  the  patients  who  declined  to  complete  hrQL
questionnaires as being men, smokers, those with a long duration of
alcohol consumption and patients free of pain.
10
Socioeconomic Impact
hrQL  and  the  socioeconomic  impact  of  disease  are  interlinked. 
A  number  of  studies  have  identified  that  socioeconomic  concerns
affect  younger  patients  more  than  older  patients,  leading  to  worse
hrQL.
10,11 Wehler  et  al.  demonstrated  that  unemployment  and  early
retirement  due  to  disease  burden  were  significant  independent
predictors  of  deterioration  in  most  hrQL  domains.
11 Lack  of
employment  has  also  been  shown  to  have  a  negative  influence  on
nausea, vomiting, insomnia and pancreatic pain.
12 The importance of
social rehabilitation in patients with cP and its effect on hrQL domains
should therefore not be underestimated. it could be argued that return
to employment should be considered as an important part of follow-up
assessment and outcome following interventions. 
Conclusions
Patients  with  cP  have  a  significantly  impaired  hrQL  that  affects  all
aspects of life. Treatment of such patients should therefore encompass
a multidisciplinary approach that is patient centred and focuses not just
on improving symptoms but also on social wellbeing. We believe that
hrQL questionnaires represent useful clinical tools that may help to
identify patients with the greatest needs. The choice of instrument will
be dictated by the aims of each study – the investigator can choose
between  short,  less  sensitive  hrQL  assessments  or  longer
questionnaires that provide more detailed information specific to the
disease. studies to date that have addressed the impact of different
therapies on hrQL in cP have demonstrated that there is heterogeneity
among results that may not be applicable to all populations. it is clear
that  a  number  of  treatments  are  beneficial  to  patients;  however,
clinicians  should  be  aware  of  the  lack  of  evidence  on  long-term
outcomes in improving hrQL. n
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